Clinical evaluation of the clinicopathologic and gene expression profile (CP-GEP) in patients with melanoma eligible for sentinel lymph node biopsy:A multicenter prospective Dutch study
Sentinel lymph node biopsy (SLNB) is recommended for patients with >pT1b cutaneous melanoma, and should be considered and discussed with patients diagnosed with pT1b cutaneous melanoma for the purpose of staging, prognostication and determining eligibility for adjuvant therapy. Previously, the clinicopathologic and gene expression profile (CP-GEP, Merlin Assay®) model was developed to identify patients who can forgo SLNB because of a low risk for sentinel node metastasis. The aim of this study was to evaluate the clinical use and implementation of the CP-GEP model in a prospective multicent... Mehr ...
Verfasser: |
Stassen, Robert C.
Mulder, Evalyn E.A.P.
Mooyaart, Antien L.
Francken, Anne Brecht
van der Hage, Jos
Aarts, Maureen J.B.
van der Veldt, Astrid A.M.
Verhoef, Cornelis
Grünhagen, Dirk J. |
Dokumenttyp: |
Artikel |
Erscheinungsdatum: |
2023 |
Reihe/Periodikum: |
Stassen , R C , Mulder , E E A P , Mooyaart , A L , Francken , A B , van der Hage , J , Aarts , M J B , van der Veldt , A A M , Verhoef , C & Grünhagen , D J 2023 , ' Clinical evaluation of the clinicopathologic and gene expression profile (CP-GEP) in patients with melanoma eligible for sentinel lymph node biopsy : A multicenter prospective Dutch study ' , European Journal of Surgical Oncology , vol. 49 , no. 12 , 107249 . https://doi.org/10.1016/j.ejso.2023.107249 |
Sprache: |
Englisch |
Permalink: |
https://search.fid-benelux.de/Record/base-26684263 |
Datenquelle: |
BASE;
Originalkatalog |
Powered By: |
BASE |
Link(s) :
|
https://pure.eur.nl/en/publications/623c449a-a66c-4f51-b761-5f137d5a0919 |